Literature DB >> 27438316

Evaluation of High-Sensitivity Cardiac Troponin I Levels in Patients With Suspected Acute Coronary Syndrome.

Edward Carlton1, Jaimi Greenslade2, Louise Cullen2, Richard Body3, Martin Than4, John W Pickering5, Sally Aldous4, Simon Carley3, Christopher Hammett6, Jason Kendall1, Brian Keevil3, Sarah Lord7, William Parsonage6, Kim Greaves8.   

Abstract

IMPORTANCE: Low concentrations of high-sensitivity cardiac troponin I determined on presentation to the emergency department (ED) have been shown to have an excellent negative predictive value (NPV) for the identification of acute myocardial infarction. The sensitivity, and therefore clinical applicability, of such testing strategies is unknown.
OBJECTIVE: To determine the diagnostic performance of low concentrations of high-sensitivity cardiac troponin I in patients with suspected cardiac chest pain and an electrocardiogram showing no ischemia as an indicator of acute myocardial infarction. DESIGN, SETTING, AND PARTICIPANTS: A pooled analysis of 5 international (Australia, New Zealand, and England) prospective, observational cohort studies with blinded outcome assessment and 30-day follow-up was conducted. A total of 3155 patients presenting with symptoms suggestive of cardiac ischemia were included in the analysis. Eligible patients had a nonischemic electrocardiogram determined and high-sensitivity troponin I measured at presentation. The lower limit of detection (1.2 ng/L) as well as cutoff concentrations rounded to the nearest integer for a high-sensitivity troponin I assay were used in the analysis. Recruitment was undertaken from November 1, 2007, to August 10, 2013. MAIN OUTCOMES AND MEASURES: The primary outcome was fatal or nonfatal acute myocardial infarction occurring within 30 days of ED presentation, adjudicated with serial troponin testing. The secondary outcome was the proportion of patients potentially suitable for early discharge at each cutoff concentration.
RESULTS: Of the 3155 eligible patients, 1771 were male (56.1%), and mean (SD) age was 57.4 (13.3) years. Acute myocardial infarction developed in 291 individuals (9.2%). The 1.2-ng/L limit of detection gave a sensitivity of 99.0% (95% CI, 96.8%-99.7%) and an NPV of 99.5% (95% CI, 98.4%-99.9%). This cutoff level would allow for early discharge of 594 patients (18.8%). All higher rounded cutoff values had sensitivities less than 98.0%. Diagnostic performance of the limit of detection was maintained when patients were stratified by age, sex, risk factors, presence of coronary artery disease, and early presentation. CONCLUSIONS AND RELEVANCE: High-sensitivity troponin I concentrations determined at presentation to the ED that were below the limit of detection identified 18.8% of patients potentially suitable for discharge, with a high sensitivity for acute myocardial infarction. Rounded cutoff values above the limit of detection may not have the required sensitivity for clinical implementation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27438316     DOI: 10.1001/jamacardio.2016.1309

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  23 in total

Review 1.  High-sensitivity assays for troponin in patients with cardiac disease.

Authors:  Dirk Westermann; Johannes Tobias Neumann; Nils Arne Sörensen; Stefan Blankenberg
Journal:  Nat Rev Cardiol       Date:  2017-04-06       Impact factor: 32.419

2.  Biomarkers: Sensitivity of troponins for diagnosis and risk prediction.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2016-06-30       Impact factor: 32.419

3.  When laboratory tests can mislead even when they appear plausible.

Authors:  Adel Aa Ismail
Journal:  Clin Med (Lond)       Date:  2017-07       Impact factor: 2.659

4.  Rapid rule-out of suspected acute coronary syndrome in the Emergency Department by high-sensitivity cardiac troponin T levels at presentation.

Authors:  Andrea Fabbri; Cristina Bachetti; Filippo Ottani; Alice Morelli; Barbara Benazzi; Sergio Spiezia; Marco Cortigiani; Romolo Dorizzi; Allan S Jaffe; Marcello Galvani
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

5.  A faster detection method for high-sensitivity cardiac troponin-POCT quantum dot fluorescence immunoassay.

Authors:  Peiling Zhou; Haohao Liu; Lan Gong; Bo Tang; Yabing Shi; Chengjian Yang; Zhijun Han
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 6.  High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages.

Authors:  Claudio Galli; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-07

7.  Heart-type fatty acid-binding protein: an overlooked cardiac biomarker.

Authors:  Harsh Goel; Joshua Melot; Matthew D Krinock; Ashish Kumar; Sunil K Nadar; Gregory Y H Lip
Journal:  Ann Med       Date:  2020-08-04       Impact factor: 4.709

Review 8.  Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome.

Authors:  Andrew R Chapman; Kuan Ken Lee; David A McAllister; Louise Cullen; Jaimi H Greenslade; William Parsonage; Andrew Worster; Peter A Kavsak; Stefan Blankenberg; Johannes Neumann; Nils A Sörensen; Dirk Westermann; Madelon M Buijs; Gerard J E Verdel; John W Pickering; Martin P Than; Raphael Twerenbold; Patrick Badertscher; Zaid Sabti; Christian Mueller; Atul Anand; Philip Adamson; Fiona E Strachan; Amy Ferry; Dennis Sandeman; Alasdair Gray; Richard Body; Brian Keevil; Edward Carlton; Kim Greaves; Frederick K Korley; Thomas S Metkus; Yader Sandoval; Fred S Apple; David E Newby; Anoop S V Shah; Nicholas L Mills
Journal:  JAMA       Date:  2017-11-21       Impact factor: 56.272

9.  Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial Infarction.

Authors:  Andrew R Chapman; Atul Anand; Jasper Boeddinghaus; Amy V Ferry; Dennis Sandeman; Philip D Adamson; Jack Andrews; Stephanie Tan; Sheun F Cheng; Michelle D'Souza; Kate Orme; Fiona E Strachan; Thomas Nestelberger; Raphael Twerenbold; Patrick Badertscher; Tobias Reichlin; Alasdair Gray; Anoop S V Shah; Christian Mueller; David E Newby; Nicholas L Mills
Journal:  Circulation       Date:  2016-12-29       Impact factor: 29.690

10.  High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome.

Authors:  Eve Miller-Hodges; Atul Anand; Anoop S V Shah; Andrew R Chapman; Peter Gallacher; Kuan Ken Lee; Tariq Farrah; Nynke Halbesma; James P Blackmur; David E Newby; Nicholas L Mills; Neeraj Dhaun
Journal:  Circulation       Date:  2017-10-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.